文献速递创伤骨科关节外科

手术入路对移位型囊内髋骨折全髋关节置换结局的影响:英国国家关节登记分析

The Effect of Surgical Approach on Outcomes Following Total Hip Arthroplasty Performed for Displaced Intracapsular Hip Fractures: An Analysis from the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man.
PubMed 文献 · J Bone Joint Surg Am · 2020-01-01

该研究回顾性分析2003至2015年英国国家关节登记中因髋骨折行股骨柄初次全髋关节置换的病例,经倾向评分匹配后比较后侧与 anterolateral 入路。匹配后14,536例THA(每组7,268例),两入路5年无翻修生存率相似,但后侧入路患者30天、1年及5年生存率更高,术中并发症风险更低。

要点

  • 后侧与 anterolateral 入路5年无翻修生存率相似(97.3% vs 97.4%;SHR 1.15)。
  • 后侧入路30天患者生存率更高(99.5% vs 98.8%;HR 0.44),1年及5年持续。
  • 后侧入路术中并发症风险更低(OR 0.59;95%CI 0.45–0.78)。

核心结论

  • 因髋骨折行全髋关节置换时,后侧入路与 anterolateral 入路相比翻修风险相似,且患者死亡率和术中并发症风险更低。

研究设计与样本

  • 回顾性分析英国国家关节登记中2003至2015年因髋骨折行股骨柄初次全髋关节置换的病例,采用倾向评分匹配后比较后侧与 anterolateral 入路,匹配后共14,536例THA(每组7,268例)。

主要发现

  • 匹配后5年无翻修累积生存率后侧组97.3% vs anterolateral 组97.4%(SHR 1.15;95%CI 0.93–1.42)。
  • 5年无脱位翻修生存率SHR 1.28(95%CI 0.89–1.84),无假体周围骨折翻修生存率SHR 1.03(95%CI 0.68–1.56),两组相当。
  • 30天患者生存率后侧组99.5% vs anterolateral 组98.8%(HR 0.44;95%CI 0.30–0.64),1年HR 0.73(95%CI 0.64–0.84),5年HR 0.87(95%CI 0.81–0.94)。
  • 后侧入路术中并发症风险更低(OR 0.59;95%CI 0.45–0.78)。

关键数值与推荐

  • 5年无翻修累积生存率:后侧组97.3% vs anterolateral 组97.4%(SHR 1.15;95%CI 0.93–1.42)。
  • 30天患者生存率:后侧组99.5% vs anterolateral 组98.8%(HR 0.44;95%CI 0.30–0.64)。
  • 术中并发症:后侧入路OR 0.59(95%CI 0.45–0.78)。

临床怎么用

  • 因髋骨折行全髋关节置换时,后侧入路与 anterolateral 入路同样安全,可根据术者偏好选择任一种入路。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Studies have suggested that the anterolateral approach is preferable to the posterior approach when performing total hip arthroplasty (THA) for a displaced intracapsular hip fracture, because of a perceived reduced risk of reoperations and dislocations. However, this suggestion comes from small studies with short follow-up. We determined whether surgical approach in THAs performed for hip fracture affects revision-free hip survival, patient survival, and intraoperative complications. METHODS: We retrospectively analyzed all stemmed primary THAs for hip fracture that were recorded in the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man that were performed between 2003 and 2015. The 2 surgical approach groups, posterior and anterolateral, were matched for patient and surgical confounding factors using propensity scores, with outcomes compared using regression modeling (with regression model ratios of <1 representing a reduced risk of the specified outcome in the posterior group). Outcomes were 5-year hip survival free from revision (all-cause revision, revision for dislocation and/or subluxation, and revision for periprosthetic fracture), patient survival (30 days, 1 year, and 5 years postoperatively), and intraoperative complications. RESULTS: After matching, 14,536 THAs (7,268 per group) were studied. Five-year cumulative revision-free survival rates were similar (posterior group, 97.3%, and anterolateral group, 97.4%; subhazard ratio [SHR], 1.15 [95% confidence interval (CI), 0.93 to 1.42]). Five-year survival rates free from revision for dislocation (SHR, 1.28 [95% CI, 0.89 to 1.84]) and for periprosthetic fracture (SHR, 1.03 [95% CI, 0.68 to 1.56]) were also comparable between the 2 approach groups. Thirty-day patient survival was significantly higher following a posterior approach (99.5% compared with 98.8%; hazard ratio [HR], 0.44 [95% CI, 0.30 to 0.64]), which persisted at 1 year (HR, 0.73 [95% CI, 0.64 to 0.84]) and 5 years (HR, 0.87 [95% CI, 0.81 to 0.94]) postoperatively. The posterior approach was associated with a lower risk of intraoperative complications (odds ratio [OR], 0.59 [95% CI, 0.45 to 0.78]). CONCLUSIONS: In THA for hip fracture, the posterior approach was associated with a similar risk of revision and a lower risk of both patient mortality and intraoperative complications compared with the anterolateral approach. We propose that the posterior approach is as safe as the anterolateral approach when performing THA for hip fracture and that either approach may be used according to surgeon preference. LEVEL OF EVIDENCE: Therapeutic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Matharu GS, Judge A, Deere K, et al. The Effect of Surgical Approach on Outcomes Following Total Hip Arthroplasty Performed for Displaced Intracapsular Hip Fractures: An Analysis from the National Joint Registry for England, Wales, Northern Ireland and the Isle of Man. J Bone Joint Surg Am. 2020. PMID: 31663927. doi:10.2106/JBJS.19.00195

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。